Form D · Biotechnology
Nanovis, LLC
Columbia City, IN · CIK 0001464933
Offering snapshot reported Mar 27, 2020 · SEC filing
- Reported sold
- $5.41M Indefinite offering
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Feb 18, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 27, 2020 | Initial | $5,413,520 | No comparison | 5 | SEC filing |
| Sep 14, 2017 | Initial | $769,548 | No comparison | 5 | SEC filing |
| Sep 16, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Sep 16, 2016 | Initial | $1,100,000 | No comparison | 3 | SEC filing |
| Dec 14, 2015 | Initial | $750,000 | No comparison | 1 | SEC filing |
| Jan 9, 2015 | Initial | $2,500,000 | No comparison | 1 | SEC filing |
| Aug 5, 2014 | Initial | $372,065 | No comparison | 5 | SEC filing |
| Mar 7, 2013 | Initial | $70,000 | No comparison | 1 | SEC filing |
| Dec 6, 2011 | Amendment | $225,000 | No comparison | 3 | SEC filing |
| Jul 13, 2011 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 3, 2009 | Initial | $100,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b, 4a5
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $220K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-363833
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| COMMENDA SECURITIES, LLC | 164664 |
Source: Form D, filed Mar 27, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Emerick | Director, Executive |
| Steve Gerrish | Director |
| V. Edward Grogg | Director |
| V Edward Grogg | Director |
| Matthew Hedrick | Director, Executive |
| Christopher Lamothe | Director |
| Brian More | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5865 E. State Road 14
Columbia City, IN, 46725
Columbia City, IN, 46725